Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Polycystic Ovary Syndrome × Surveys and Questionnaires × Clear all

Status

Completed 3 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 9 Prostatic Neoplasms 8 Head and Neck Neoplasms 8 Colorectal Neoplasms 8 Motor Activity 6 Breast Neoplasms 6 Ovarian Neoplasms 4 Multiple Myeloma 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Oropharyngeal Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Mouth Neoplasms 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Leiomyoma 2 Hematological Cancer 2 Hematologic Neoplasms 2 Colonic Neoplasms 2 COVID-19 2 Brain Neoplasms 2 Wilms Tumor 1 Venous Thromboembolism 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

Metformin 30 Clomiphene 8 Letrozole 7 Triptorelin Pamoate 5 Inositol 5 drospirenone and ethinyl estradiol combination 4 Progesterone 4 Ethinyl Estradiol 4 Acupuncture Therapy 4 drospirenone 3 cetrorelix 3 Folic Acid 3 Estradiol 3 Diet, Mediterranean 3 Diet 3 Cyproterone acetate, ethinyl estradiol drug combination 3 Contraceptives, Oral 3 adrenosterone 2 Ultrasonography 2 Therapeutics 2 Spironolactone 2 Sitagliptin Phosphate 2 Simvastatin 2 Musculoskeletal Manipulations 2 Hematologic Tests 2 Gonadotropins 2 Flutamide 2 Dydrogesterone 2 Dexamethasone 2 Dehydroepiandrosterone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05982236 2023-08-25

SPICE

University Hospital, Lille

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡